Institut Claudius Regaud clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 117 studies whose lead sponsor is Institut Claudius Regaud. 34 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2026.
Keep track of what changes. Save the Institut Claudius Regaud studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Institut Claudius Regaud leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 117. Browse all 117 →
- Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue SarcomaRecruitingNCT04307277Phase 3
- PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical CancerRecruitingNCT05581121Phase 3
- Irradiation in Paediatrics: Neurocognition, Neuroimaging and Evaluation of Memory and AttentionRecruitingNCT06599879Not applicable
- Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.RecruitingNCT07195344Phase 4
- Study for Characterisation of Predictive Parameters of Clonal Evolution in Subjects With GATA2 Germline MutationRecruitingNCT05983991Not applicable
- Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian CancerRecruitingNCT07821879
- Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Patients Receiving Oral Treatment for Cancer or Malignant Haemopathy (ACCELER PLATFORM)RecruitingNCT06797037Not applicable
- Impact of Pesticide Exposure on Survival and Tumor Aggressiveness in Patients With Glioblastoma: A Prospective Clinical StudyNot yet recruitingNCT07788430Not applicable
- Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage CancerRecruitingNCT07427186Not applicable
- Male breAsT cAncer preDisposition Factor: Creation of a Control Cohort 2Not yet recruitingNCT07558343Not applicable
- Evaluation of the Inflammation-based Index as a Predictive Marker of Clinical and Radiological Response in Patients Treated With Lu-177 Oxodotreotide for Intestinal Neuroendocrine TumourRecruitingNCT06876532Not applicable
- Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer ImmunotherapyRecruitingNCT03514368Not applicable
- Acceptability and Benefits of an Onco-sexology Program for Laryngectomy Patients and Their PartnersRecruitingNCT06517355
- Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic CancersRecruitingNCT06967961Not applicable
- Multiomic Approach to Radioresistance of Ependymomas in Children and AdolescentsRecruitingNCT05151718
- A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.RecruitingNCT06022159Phase 2
- Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate CancerRecruitingNCT06904625Not applicable
- Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast CancerRecruitingNCT04740697Not applicable
- Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.RecruitingNCT05378204Not applicable
- Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed GlioblastomaRecruitingNCT06222138Not applicable
- Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma GroupRecruitingNCT03967834Not applicable
- Breast Cancer Organelle Properties and Protein Expression Atlas in the Three Immunohistochemical Subtypes of Breast CancersRecruitingNCT07233928Not applicable
- Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.RecruitingNCT06022016Not applicable
- Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance TherapyRecruitingNCT06588322Not applicable
- Platino-resistance in Ovarian CancerRecruitingNCT03954171Not applicable
- Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic TherapyRecruitingNCT04428554Phase 2
- Prostate Cancer Burden and Heterogeneity Evaluation Towards Liquid Biopsy: a Correlation Study to 18FDCFPyL PET and Patients OutcomeRecruitingNCT06917781Not applicable
- Deciphering Mechanisms Underlying Cancer ImmunogenicityRecruitingNCT03958240Not applicable
- Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site SequelaeRecruitingNCT05757817Not applicable
- Efficacy of Pre-operative Prehabilitation in Patients With Limb SarcomaRecruitingNCT04515459Phase 2
- Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)RecruitingNCT04940000Not applicable
- Blocking TNF to Potentiate the ICI-dependent Immune Awakening in MelanomaRecruitingNCT05867004
- Prospective Melanoma DatabaseRecruitingNCT02884362
- Prospective and Retrospective Breast Cancer DatabaseRecruitingNCT02884284
- Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid CarcinomaCompletedNCT00144976Not applicable
- Determination of Carboplatin's Optimal Plasmatic ExposureCompletedNCT00145028Not applicable
- Interest of Medical Hypnosis in Anxious Patients Treated by RadiotherapyActive, not recruitingNCT04513444Phase 2
- Vorinostat in Combination With Vinorelbine in Patients With Advanced CancerTerminatedNCT00801151Phase 1
- Evaluation of a Pneumotachograph (SPI) for the Production of PET and CT Acquisitions Synchronized With Breath for the Assessment of Extension of Lung CancerTerminatedNCT01720186Not applicable
- Accompaniment of Patients by Dental Assistants in the Evaluation of Oral Hygiene During and After Radiotherapy Treatment.CompletedNCT05494970
- Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE).CompletedNCT03447483Not applicable
- Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic SarcomaCompletedNCT05821231Phase 1
- Anthropological, Socio-cultural and Psychological Surgeons' Factors in Oncology and Brakes for Evaluation of InnovationsCompletedNCT05865964
- Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell CarcinomasActive, not recruitingNCT06557889Phase 2
- Analytical Validation of Circulating DNA Analysis Methods: Creation of a Control CohortCompletedNCT07663994Not applicable
- A Prospective Study to Collect Images in Patients Treated With Iodine-131 as Part of a European Research Project in Radiation Protection.CompletedNCT03986437
- Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma MultiformeCompletedNCT00209989Phase 2
- Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual ThyrocalcitoninCompletedNCT02856347Not applicable
- Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility StudyCompletedNCT06589414Not applicable
- Male breAsT cAncer preDisposition FactorCompletedNCT06219187